Markels John

Markels John is listed in filings as Director at Sangamo Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 16, 2025, including 5 public disclosures. Recent filings connect the profile to Sangamo Therapeutics, Inc. (SGMO) and Arcturus Therapeutics Holdings Inc. (ARCT). The current snapshot covers public activity from Jun 18, 2024 to Jun 16, 2025. Reported amounts are shown as $25.1K to $465.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.